Women Corporate Directors S&P 500 Directors' Summit

Accelerated Transformation:
Perspectives from the Boardroom

You are cordially invited to attend the Women Corporate Directors Global Large-Cap Directors' Summit.

This exclusive event is designed for female directors of the largest companies currently trading on major U.S. or global stock exchanges. The Summit offers attendees an opportunity to share perspectives on pressing boardroom issues, while also engaging with peers in an intimate and dynamic setting. There is no cost for invited guests to participate, but space is limited, so please register early.

There is no cost for invited guests to participate, but space is limited.

2:00 p.m. – 6:00 p.m. Program and roundtable discussions
6:00 p.m. – 6:30 p.m. Networking reception
6:30 p.m. – 8:00 p.m. Dinner and fireside chat with Dr. Noubar Afeyan

Topics and Speakers

Welcoming Comments

Camile Asaro
Audit Partner, Investment Management, KPMG LLP, Lead Director, Women Corporate Directors Foundation
  Paul Knopp
Chair and CEO, KPMG LLP
Lessons in Leadership – Case Studies from the Pandemic

During the past two years of pandemic disruption, corporate leaders and directors experienced rapid change to business models, evolving workforce needs, and uncertainty in capital markets. Some companies thrived under this pressure, while others struggled. Hear from our panelists about their leadership journey, their pitfalls, and successes.


Pamela Reeve
Chair, American Tower Corp; director, Dental Service of Massachusetts, DentaQuest, and General Hospital Corporation 
  Jennifer Reynolds 
(Moderator),CEO, Women Corporate Directors Foundation; director, BF&M Ltd., Canada Development Investment Corporation and former director of Citibank Canada
  Dr. Nadja West
Lt. General, U.S. Army (retired); director, Johnson & Johnson, Nucor, and Tenet Healthcare

The Evolving ESG and Climate Challenge

The business environment today has created a renewed focus on ESG, due in large part to shareholder and stakeholder demands. Are companies looking at ESG as a “check-the-box” exercise, or are they embedding ESG initiatives into the strategic plan and corporate culture? How are boards providing strategic guidance and holding management accountable for meeting metrics to define success?


Lynda Clarizio
Director, CDW Corp, Taboola.com Ltd, Simplifi Holdings, Inc., Intertek Group Plc, Emerald Holding, Inc., Outrigger, Inc., and Resonate Networks, Inc.
  Mindy Lubber 
(Moderator), CEO, Coalition for Environmentally Responsible Economies, Inc. (CERES)
  Nichelle Maynard-Elliott
Director, Xerox, Element Solutions, Inc., and Lucid Group, Inc.
  Linda Addison
Independent Director, Globe Life Inc., Good Works II Acquisition Corp., and KPMG LLP

Redefining What’s Possible with Emerging Technology

Innovations such as Artificial Intelligence, Robots, Gene Editing, Virtual Worlds, Quantum Computing and Cryptocurrency are among the emerging technologies that are redefining business models. Our panel will explore the latest trends, applications, and what the board should know about associated risks and opportunities.   


Dr. Asha Collins
General manager, DNAnexus, Inc.; director, IDEXX Laboratories; and co-lead, Pipeline Angels
  Dr. Sophie Vandebroek
Director, IDEXX Laboratories, Inari Agriculture, and Wolters Kluwer NV
  Maggie Wilderotter
(Moderator), CEO, Grand Reserve Inn & Vineyard; director, Costco, DocuSign, Hewlett Packard Enterprise, Lyft, Sana Biotechnology, Sonoma Biotherapeutics, and Tanium
  Marie Wieck
Executive partner, Ethos Capital; director, Daimler Truck AG, Intapp, Inc., and Uptake Technologies

From Theory to Reality in Record Time: How Breakthrough Innovation Transformed the Trajectory of the COVID-19 Pandemic

Speed to market took on new meaning for pharmaceutical, biotechnology, and healthcare companies at the onset of COVID-19. During this fireside chat, moderated by WCD member Sophie Vandebroek, you will hear from Noubar Afeyan, Ph.D., the founder and CEO of Flagship Pioneering and co-founder and chairman of Moderna. Dr. Afeyan will share more about Moderna’s path to creating their mRNA vaccine for COVID-19, Flagship’s unique approach to innovation, and his reflections on the future of biotech. 


Dr. Noubar Afeyan
Founder and CEO, Flagship Pioneering; co-founder and chairman, Moderna; director of other Biotech companies
  Dr. Sophie Vandebroek
(Moderator), director, IDEXX Laboratories, Inari Agriculture, and Wolters Kluwer NV


The St. Regis Hotel is offering attendees a $100.00 discount off a superior room on April 7. To book your room, please click here.

As an alternative, we recommend the hotels located below that have a lower nightly rate and are within walking distance of the St. Regis. 

Le Meridien Central Park 120 West 57th Street, New York, NY 10019
Conrad New York Midtown 151 West 54th Street, New York, NY 10019
JW Marriott Essex House 160 Central Park South, New York, NY 10019
New York Hilton Midtown 1336 Avenue of the Americas, New York, NY 10019

COVID-19 Safety

Please note, due to the executive order issued by New York City, all event attendees are currently required to provide proof of vaccination the day of the event to be allowed entry into the St. Regis Hotel meeting rooms. 

WCD recommends that attendees either bring a photo of their vaccination card or their physical card. There is also the option to download the New York City COVID Safe Pass to your Android or Apple smartphone and then upload an image of the vaccination card.  

If you have questions or require additional information, please email us at [email protected]

4/7/2022 2:00 PM - 8:00 PM
The St. Regis New York Two East 55th Street at Fifth Avenue New York 10022

Registering for an event requires you to first be logged into the WCD website.

New to the WomenCorporateDirectors site?
If you do not have an account or have never logged into our site before, youwill need to create an account by clicking here to login and proceed with event registration.

WCD Members please sign in below to continue with event registration.

Sign In